Activity-dependent increase in beta-amyloid precursor protein mRNA expression in neurons

Akiko Tabuchi1, Asami Ishii, Mamoru Fukuchi

  • 1Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Sugitani 2630, Toyama 930-0194, Japan.

Neuroreport
|May 29, 2004
PubMed

Insights

Beta-amyloid precursor protein (APP) mRNA expression in neurons is regulated by neuronal activity. High potassium levels increase APP mRNA, while reduced activity decreases it, highlighting activity-dependent control.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Beta-amyloid precursor protein (APP) is implicated in neuronal survival and plasticity.
  • The regulation of APP mRNA expression by neuronal activity remains largely uncharacterized.

Purpose of the Study:

  • To investigate the relationship between neuronal activity and APP mRNA expression in neurons.
  • To elucidate the mechanisms underlying activity-dependent regulation of APP mRNA.

Main Methods:

  • Primary cultures of mouse cerebellar granule cells were used.
  • Neuronal activity was manipulated by altering extracellular potassium (K+) concentration.
  • APP mRNA and protein levels were quantified.
  • Calcium influx and protein synthesis pathways were examined.

Main Results:

  • High potassium concentrations significantly increased APP mRNA levels.
  • Depolarization-induced K+ deprivation reduced both APP mRNA expression and protein synthesis.
  • Restoring high K+ concentrations restored APP mRNA expression.
  • This regulation was dependent on calcium (Ca2+) influx via L-type voltage-dependent calcium channels and de novo protein synthesis.

Conclusions:

  • APP mRNA expression in neurons is controlled in an activity-dependent manner.
  • Neuronal activity, specifically membrane depolarization, modulates APP gene expression.
  • Calcium signaling pathways are crucial for this activity-dependent regulation of APP.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...